Myriad Genetics Aktie
14,20
EUR
-0,10
EUR
-0,70
%
14,94
USD
-0,27
USD
-1,74
%
Myriad Genetics Aktie Analyse
| 01.08.19 | Myriad Genetics Equal weight | Barclays Capital | |
| 29.07.19 | Myriad Genetics Hold | Needham & Company, LLC | |
| 09.07.19 | Myriad Genetics Market Perform | Cowen and Company, LLC | |
| 12.03.19 | Myriad Genetics Strong Buy | Needham & Company, LLC | |
| 03.01.19 | Myriad Genetics Strong Buy | Needham & Company, LLC | |
| 22.01.18 | Myriad Genetics Equal weight | Barclays Capital | |
| 05.01.18 | Myriad Genetics Buy | BTIG Research | |
| 09.08.17 | Myriad Genetics Equal weight | Barclays Capital | |
|
Werbung
|
|||
| 18.01.17 | Myriad Genetics Sell | Deutsche Bank AG | |
| 04.05.16 | Myriad Genetics Neutral | Mizuho | |
| 07.01.16 | Myriad Genetics Buy | Deutsche Bank AG | |
| 07.01.16 | Myriad Genetics overweight | Barclays Capital | |
| 04.11.15 | Myriad Genetics Neutral | Mizuho | |
| 15.09.15 | Myriad Genetics Neutral | Mizuho | |
| 21.07.15 | Myriad Genetics Buy | Gabelli & Co | |
| 10.03.15 | Myriad Genetics Sell | UBS AG | |
| 04.02.15 | Myriad Genetics Neutral | Mizuho | |
| 07.01.15 | Myriad Genetics overweight | Barclays Capital | |
| 07.11.12 | Myriad Genetics perform | Oppenheimer & Co. Inc. | |
| 07.11.12 | Myriad Genetics hold | Jefferies & Company Inc. | |
| 16.08.12 | Myriad Genetics outperform | RBC Capital Markets | |
| 16.08.12 | Myriad Genetics outperform | RBC Capital Markets | |
| 03.07.12 | Myriad Genetics buy | Goldman Sachs Group Inc. | |
| 26.01.12 | Myriad Genetics outperform | RBC Capital Markets | |
| 18.10.11 | Myriad Genetics neutral | Citigroup Corp. | |
| 11.08.11 | Myriad Genetics sell | Goldman Sachs Group Inc. | |
| 17.03.11 | Myriad Genetics perform | Oppenheimer & Co. Inc. | |
| 02.03.11 | Myriad Genetics sell | Goldman Sachs Group Inc. | |
| 24.02.11 | Myriad Genetics sell | Goldman Sachs Group Inc. | |
| 03.11.10 | Myriad Genetics neutral | UBS AG | |
| 13.10.10 | Myriad Genetics outperform | RBC Capital Markets | |
| 03.08.10 | Myriad Genetics neutral | UBS AG | |
| 06.05.10 | Myriad Genetics halten | Citigroup Corp. | |
| 06.05.10 | Myriad Genetics halten | Morgan Stanley | |
| 26.04.10 | Myriad Genetics kaufen | JP Morgan Chase & Co. | |
| 27.08.09 | Myriad Genetics equal-weight | Morgan Stanley | |
| 04.08.09 | Myriad Genetics outperform | William Blair | |
| 17.07.09 | Myriad Genetics buy | Soleil Securities Group, Inc. | |
| 02.07.09 | Myriad Genetics overweight | Piper Jaffray & Co. | |
| 02.07.09 | Myriad Genetics outperform | Leerink Swann LLC | |
| 01.07.09 | Myriad Genetics sector perform | RBC Capital Markets | |
| 01.07.09 | Myriad Genetics perform | Oppenheimer & Co. Inc. | |
| 01.07.09 | Myriad Genetics buy | UBS AG | |
| 06.05.09 | Myriad Genetics buy | UBS AG | |
| 09.04.09 | Myriad Genetics outperform | RBC Capital Markets | |
| 24.03.09 | Myriad Genetics outperform | Leerink Swann LLC | |
| 05.02.09 | Myriad Genetics market outperform | JMP Securities LLC | |
| 05.02.09 | Myriad Genetics buy | UBS AG | |
| 04.02.09 | Myriad Genetics outperform | RBC Capital Markets | |
| 05.01.09 | Myriad Genetics buy | Piper Jaffray & Co. | |